WESTERN ASSET EMRG MRKT DBT (EMD) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:EMD - US95766A1016
EMD Key Statistics, Chart & Performance
The current stock price of EMD is 10.66 USD. In the past month the price increased by 2.78%. In the past year, price increased by 5.73%.
EMD Latest News, Press Relases and Analysis
WESTERN ASSET EMRG MRKT DBT / EMD FAQ
Can you describe the business of WESTERN ASSET EMRG MRKT DBT?
Western Asset Emerging Markets Debt Fund Inc is a US-based company operating in industry. The company is headquartered in New York City, New York. The company went IPO on 2003-12-02. Western Asset Emerging Markets Debt Fund Inc. (the Fund) is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to seek high current income, and its secondary objective is to seek capital appreciation. The company invests primarily in the United States (U.S.) dollar and non-United States dollar denominated debt securities of issuers in emerging market countries. The Fund invests at least 80% of its managed assets in debt securities of issuers in emerging market countries. The Fund may invest up to 20% of its managed assets in non-debt securities and non-emerging market issuers, including equity securities. The company may invest in securities denominated in currencies of emerging market countries. The Fund seeks to maintain an average portfolio duration between 20% above and 20% below the average duration of the JPMorgan Emerging Markets Bond Index Global Diversified. Its investment manager is Franklin Templeton Fund Adviser, LLC.
What is the stock price of WESTERN ASSET EMRG MRKT DBT today?
The current stock price of EMD is 10.66 USD. The price decreased by -0.47% in the last trading session.
What is the ChartMill technical and fundamental rating of EMD stock?
EMD has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
EMD Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to EMD. When comparing the yearly performance of all stocks, EMD turns out to be only a medium performer in the overall market: it outperformed 60.25% of all stocks.